drugset / Trial / NCT05165212

Primary Care Amoxicillin Challenge

NCT05165212 ↗

NaSingle-groupOpen-labelOther

Summary

The purpose of this project is to identify clinic patients reporting penicillin allergy who are low risk for allergic reaction, and then invite them to participate in an oral amoxicillin challenge in their primary office without need for referral to allergy/immunology. If the patient is able to tolerate oral amoxicillin, the antibiotic allergy in question will be removed from the patient's chart.

Timeline

Start
2024-12-31
Primary completion
2025-12-31
Completion
2026-01-01

Outcome

Outcome not reported

Stopped: “Unable to host study at clinic site.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified — Oral